KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Minority Interest: 2017-2025

Historic Minority Interest for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $67.8 million.

  • Amneal Pharmaceuticals' Minority Interest rose 13.18% to $67.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year increase of 13.18%. This contributed to the annual value of $65.0 million for FY2024, which is 57.35% up from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Minority Interest is $67.8 million, which was up 3.01% from $65.8 million recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Minority Interest registered a high of $72.6 million during Q1 2025, and its lowest value of $13.1 million during Q1 2021.
  • Over the past 3 years, Amneal Pharmaceuticals' median Minority Interest value was $53.4 million (recorded in 2024), while the average stood at $51.8 million.
  • Data for Amneal Pharmaceuticals' Minority Interest shows a peak YoY skyrocketed of 79.51% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Minority Interest stood at $16.9 million in 2021, then soared by 47.57% to $24.9 million in 2022, then spiked by 65.51% to $41.3 million in 2023, then soared by 57.35% to $65.0 million in 2024, then rose by 13.18% to $67.8 million in 2025.
  • Its Minority Interest was $67.8 million in Q3 2025, compared to $65.8 million in Q2 2025 and $72.6 million in Q1 2025.